Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-20-013020
Date:2020-02-24
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
Original Submission Date:

Reporting Person:

ARBUCKLE STUART A
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE BOSTON, MA 02210

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-02-24 F 2,898 d $239.23 38,813 direct
COMMON STOCK 2020-02-25 S 810 d $229.78 38,003 direct
COMMON STOCK 2020-02-25 S 432 d $230.85 37,571 direct
COMMON STOCK 2020-02-25 S 360 d $232.35 37,211 direct
COMMON STOCK 2020-02-25 S 420 d $234.08 36,791 direct
COMMON STOCK 2020-02-25 S 540 d $235.14 36,251 direct
COMMON STOCK 2020-02-25 S 420 d $236.36 35,831 direct
COMMON STOCK 2020-02-25 S 20 d $236.88 35,811 direct
COMMON STOCK 2020-02-25 S 632 d $238.33 35,179 direct
COMMON STOCK 2020-02-24 0 $0.00 140 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 transaction made pursuant to mr. arbuckle's company approved trading plan under rule 10b5-1.
f2 open market sales reported on this line occurred at a weighted average price of $229.78 (range $229.21 to $230.14).
f3 mr. arbuckle undertakes to provide (upon request by the sec staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
f4 open market sales reported on this line occurred at a weighted average price of $230.85 (range $230.51 to $231.30).
f5 open market sales reported on this line occurred at a weighted average price of $232.35 (range $232.03 to $232.72).
f6 open market sales reported on this line occurred at a weighted average price of $234.08 (range $233.57 to $234.44).
f7 open market sales reported on this line occurred at a weighted average price of $235.14 (range $234.61 to $235.56).
f8 open market sales reported on this line occurred at a weighted average price of $236.36 (range $235.69 to $236.65).
f9 open market sales reported on this line occurred at a weighted average price of $238.33 (range $237.98 to $238.54).
WhaleWisdom Logo

Elevate your investments